Apnimed, Inc. Common StockAPMD
▲ PositiveCapitalrelevance
Added to NASDAQ Composite Index, increasing visibility and liquidity for index-following investors.
Impact on stocks 1
Others
Apnimed, Inc. Common StockApnimed has been added to the NASDAQ Composite Index, increasing its visibility among index-following investors. The inclusion can lead to higher trading liquidity as more funds and investors track or reference the NASDAQ Composite. The move is often viewed as recognition of a company's progress and operational milestones within the public markets. Apnimed is a US pharmaceutical company with a market cap of $1.1b that focuses on developing oral therapies targeting the neurobiology of sleep-related breathing diseases in global markets. The company still faces underlying financial questions, including weak coverage of debt by operating cash flow and negative shareholders equity.
Apnimed, Inc. Common StockAdded to NASDAQ Composite Index, increasing visibility and liquidity for index-following investors.